Karina Perez Sacardo

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient

Maurício Fernando Silva Almeida Ribeiro, Franciele Hinterholz Knebel, Fabiana Bettoni et al. · npj Precision Oncology · 2021 · 41 citations · Full text

Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors

Yoshihisa Kobayashi, Geoffrey R. Oxnard, Elizabeth F. Cohen et al. · Nature Communications · 2022 · 27 citations · Full text

Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer

Shah Zeb Khan, Luca Arecco, Cynthia Villarreal‐Garza et al. · JCO Global Oncology · 2022 · 26 citations · Full text

Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series

Maurício Fernando Silva Almeida Ribeiro, Joao V. Alessi, Leandro Jonata de Carvalho Oliveira et al. · Lung Cancer · 2019 · 18 citations · Full text

Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil

Marcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro et al. · Cancer Treatment and Research Communications · 2023 · 17 citations · Full text